Risk Management Plan
Organisation:
Pieter Niels
Dr Katharina Hartmann
Katharina is a seasoned pharmacovigilance expert with over 35 years of experience in vaccine safety. She led national and global PV systems at the Swiss Drug Monitoring Center, Crucell, J&J, and Takeda, establishing and integrating major vaccine PV frameworks. Since 2019, she has consulted for DCVMN and CEPI. A long‑time ETH Zurich lecturer and former president of the Swiss pharmaceutical examination board, she has also contributed to CIOMS, Brighton Definitions, and international training and publications.
Dr. Bernadette Hendrickx
Belgian citizen. Graduated in medecine at the Catholic University of Louvain , Belgium. Worked at Solvay pharmaceuticals, GSK (vaccines in Rixensart Belgium)and Sanofi Pasteur in Lyon, France where I was head of Regulatory Affairs WW and CMO (Chief Medical Officer WW).








